
|Articles|April 15, 2019
Private equity and ophthalmology: Will I be left behind?
If you find yourself waffling back and forth on private equity, Ruth D. Williams, MD, has some guidance tips to make the decision easier.
Advertisement
Ruth D. Williams, MD, shares the take-home message from her presentation, "Private Equity and Ophthalmology: Will I Be Left Behind?" at the 23rd annual Glaucoma 360 meeting at the Palace Hotel in San Francisco on Feb. 2, 2019.
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Preclinical study suggests synaptic regeneration may offer new pathway to treat glaucoma
2
Pickleball, fireworks, eyecare in space, and IRIS registry data among lead stories from day 1 of AAO 2025
3
Tensions rise between STAAR and Broadwood as proposed Alcon deal nears vote
4
Ophthalmic innovation by the decades: The 2010s
5